Last reviewed · How we verify

NCT04196400

The Role of Local Long Acting Corticosteroid Injection in Hypospadias Surgery.

Status unknown EARLY_PHASE1 Last updated 12 December 2019
What this trial tests

EARLY_PHASE1 trial testing steroid betamethasone in Hypospadias in 40 participants. Status unknown.

Timeline
1 December 2019
Primary endpoint
31 December 2020
1 March 2021

Quick facts

Lead sponsorCairo University
PhaseEARLY_PHASE1
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeprevention
Enrollment40
Start date1 December 2019
Primary completion31 December 2020
Estimated completion1 March 2021
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

6 Months and older, male only, with Hypospadias. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Post-operative tissue oedema is one of the main causes of failure of hypospadias repair. Severe oedema may disrupt the suture line, invite infection and result in repair failure. Thus, we suggested that local injection of corticosteroids in just below coronal sulcus into dartos and buck's fascia may limit this oedema thus improving the outcome of hypospadias repair.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Hypospadias

Currently open trials in the same condition.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04196400.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing